grant
GLP Toxicology Study for Adjuvanted HIV-1 Immunogen Vaccine Candidates
Organization SRI INTERNATIONALLocation MENLO PARK, UNITED STATESPosted 1 Feb 2025Deadline 1 Aug 2028
NIHUS FederalResearch GrantFY2025AIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAdjuvant StudyAdjuvant TrialsAntigensAreaClinical EvaluationClinical TestingContracting OpportunitiesContractsDevelopmentDocumentationHIVHIV-1HIV-IHIV1Human Immunodeficiency Virus Type 1Human Immunodeficiency VirusesHuman immunodeficiency virus 1Investigational DrugsInvestigational New DrugsLAV-HTLV-IIILymphadenopathy-Associated VirusNIAIDNational Institute of Allergy and Infectious DiseasePhasePreclinical TestingProcessProductionSafetyServicesToxic effectToxicitiesToxicologyVaccinesVirus-HIVadjuvant protocolclinical testdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentalflexibilityflexibleimmunogenimmunogenicitypre-clinicalpre-clinical testingpreclinicalproduct developmentprogramsresearch clinical testingvaccine candidatevaccine development
Description preview
Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS): This program will provide NIAID with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents. Contracts under this…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click